匯金股份(300368.SZ)3天2板:現有主營業務中並未涉及數字貨幣相關內容 未參與央行數字貨幣系統建設
格隆匯 8 月 6日丨匯金股份(300368.SZ)公佈,公司股票交易價格連續三個交易日收盤價格漲幅偏離值累計超過20%,根據《深圳證券交易所交易規則》的相關規定,屬於股票交易異常波動。
近期投資者和市場比較關注數字貨幣熱點,市場上出現“匯金股份作為數字貨幣概念股”等傳言,截至目前,公司主營業務主要分為智能製造業務、信息化綜合解決方案與技術服務業務及供應鏈業務,公司現有主營業務中並未涉及數字貨幣相關內容,公司未參與中國人民銀行的數字貨幣系統建設,公司也沒有相關的業務收入。特別提醒廣大投資者,注意投資風險,避免概念題材炒作,理性判斷,謹慎投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.